Nel corso della quinta BAL TALK abbiamo intervistato Maurizio Bonati, medico dell’IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Medico, Stefano Vicari, neuropsichiatra infantile dell’Ospedale Pediatrico Bambino Gesù, e Laura Reali, pediatra di famiglia. Tra i temi trattati: l’appropriatezza nell’uso degli psicofarmci, la dsiponibilità dei genitori ad accettare un approccio cognitivo-comportamentale o la prescrizione di psicofarmaci; quale dovrebbe essere l’iter ideale nella presa in carico e cosa succede in realtà. Dalle risposte emergono le grandi potenzialità della neuropsichiatria infantile italiana e le difficoltà a venire incontro a una richiesta di assistenza sproporzionata alle risorse disponibili.
Un percorso partecipato evidence-based
Intervista a Maurizio Bonati, medico, IRCCS Istituto Mario Negri
Disagio psichico: ci vuole una rete
Intervista a Laura Reali, pediatra di famiglia
La migliore cura possibile
Intervista a Stefano Vicari, neuropsichiatra infantile, Ospedale Pediatrico Bambino Gesù
Zichi C et al. Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. Eur j Canc 2021;149:49-60.
Seidler AN et al.; on behalf of the International Liaison Committee On Resuscitation Neonatal Life Support Task Force. Umbilical cord management for newborns <34 weeks' gestation: a meta-analysis. Pediatrics 2021; 147 (3) e20200576.
Gabrhelík R et al. Cannabis use during pregnancy and risk of adverse birth outcomes: a longitudinal cohort study. Eur Addict Res 2020. doi: 10.1159/000510821e
Ouldali N et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. February 1, 2021. Epub ahead of print. doi:10.1001/jama.2021.0694
Freedman RA et al. Individualizing surveillance mammography for older patients after treatment for early-stage breast cancer: multidisciplinary expert panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. Published online January 28, 2021. doi:10.1001/jamaoncol.2020.7582
Fontanella CA et al. Association of cannabis use with self-harm and mortality risk among youths with mood disorders. JAMA Pediatr. Published online January 19, 2021. doi:10.1001/jamapediatrics.2020.5494
Goldenberg JZ et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021;372:m4743
Huang J, Yang F, Chien W, et al. Risk of substance use disorder and its associations with comorbidities and psychotropic agents in patients with autism. JAMA Pediatr. Published online January 04, 2021.
Ezekowitz JA et al. Is there a sex gap in surviving an acute coronary syndrome or subsequent development of heart failure? Circulation, 30 november 2020.